IGSC 20%

immunoglobulin G 20% · Grifols Therapeutics LLC

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for IGSC 20%, covering 2019-10-04 to 2023-08-07. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate IGSC 20% Biweekly Dosing in Treatment-Experienced Participants and Loading/Maintenance Dosing in Treatment-Naïve Participants With Primary Immunodeficiency [Phase 4]

See pricing